Wang Y - Search Results

1

A role for K-ras in conferring resistance to the MEK inhibitor, CI-1040.

Wang Y, Van Becelaere K, Jiang P, Przybranowski S, Omer C, Sebolt-Leopold J. Wang Y, et al. Neoplasia. 2005 Apr;7(4):336-47. doi: 10.1593/neo.04532. Neoplasia. 2005. PMID: 15967111 Free PMC article.

2

Knockdown of Chk1, Wee1 and Myt1 by RNA interference abrogates G2 checkpoint and induces apoptosis.

Wang Y, Decker SJ, Sebolt-Leopold J. Wang Y, et al. Cancer Biol Ther. 2004 Mar;3(3):305-13. doi: 10.4161/cbt.3.3.697. Epub 2004 Mar 10. Cancer Biol Ther. 2004. PMID: 14726685 Free article.

3

Global genechip profiling to identify genes responsive to p53-induced growth arrest and apoptosis in human lung carcinoma cells.

Robinson M, Jiang P, Cui J, Li J, Wang Y, Swaroop M, Madore S, Lawrence TS, Sun Y. Robinson M, et al. Among authors: wang y. Cancer Biol Ther. 2003 Jul-Aug;2(4):406-15. doi: 10.4161/cbt.2.4.437. Cancer Biol Ther. 2003. PMID: 14508115 Free article.

4

Wild-type TP53 inhibits G(2)-phase checkpoint abrogation and radiosensitization induced by PD0166285, a WEE1 kinase inhibitor.

Li J, Wang Y, Sun Y, Lawrence TS. Li J, et al. Among authors: wang y. Radiat Res. 2002 Mar;157(3):322-30. doi: 10.1667/0033-7587(2002)157[0322:wttigp]2.0.co;2. Radiat Res. 2002. PMID: 11839095

5

Insulin-like growth factor receptor-1 as an anti-cancer target: blocking transformation and inducing apoptosis.

Wang Y, Sun Y. Wang Y, et al. Curr Cancer Drug Targets. 2002 Sep;2(3):191-207. doi: 10.2174/1568009023333863. Curr Cancer Drug Targets. 2002. PMID: 12188907 Review.

6

Role of chemotactic factors in neutrophil activation after thermal injury in rats.

Piccolo MT, Wang Y, Verbrugge S, Warner RL, Sannomiya P, Piccolo NS, Piccolo MS, Hugli TE, Ward PA, Till GO. Piccolo MT, et al. Among authors: wang y. Inflammation. 1999 Aug;23(4):371-85. doi: 10.1023/a:1020213717336. Inflammation. 1999. PMID: 10443799 Free article.

7

Chemotactic mediator requirements in lung injury following skin burns in rats.

Piccolo MT, Wang Y, Sannomiya P, Piccolo NS, Piccolo MS, Hugli TE, Ward PA, Till GO. Piccolo MT, et al. Among authors: wang y. Exp Mol Pathol. 1999 Aug;66(3):220-6. doi: 10.1006/exmp.1999.2263. Exp Mol Pathol. 1999. PMID: 10486240

8

Novel and selective spiroindoline-based inhibitors of Sky kinase.

Powell NA, Kohrt JT, Filipski KJ, Kaufman M, Sheehan D, Edmunds JE, Delaney A, Wang Y, Bourbonais F, Lee DY, Schwende F, Sun F, McConnell P, Catana C, Chen H, Ohren J, Perrin LA. Powell NA, et al. Among authors: wang y. Bioorg Med Chem Lett. 2012 Jan 1;22(1):190-3. doi: 10.1016/j.bmcl.2011.11.036. Epub 2011 Nov 16. Bioorg Med Chem Lett. 2012. PMID: 22119469

9

Treatment of Wilson's disease with zinc. VII. Protection of the liver from copper toxicity by zinc-induced metallothionein in a rat model.

Lee DY, Brewer GJ, Wang YX. Lee DY, et al. Among authors: wang yx. J Lab Clin Med. 1989 Dec;114(6):639-45. J Lab Clin Med. 1989. PMID: 2592854

10

Treatment of Wilson's disease with ammonium tetrathiomolybdate. I. Initial therapy in 17 neurologically affected patients.

Brewer GJ, Dick RD, Johnson V, Wang Y, Yuzbasiyan-Gurkan V, Kluin K, Fink JK, Aisen A. Brewer GJ, et al. Among authors: wang y. Arch Neurol. 1994 Jun;51(6):545-54. doi: 10.1001/archneur.1994.00540180023009. Arch Neurol. 1994. PMID: 8198464

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

298,036 results

Search Page

Filters